Assignee
REDWOOD PHARMA AB
SE·1 granted patent·2 pending applications·0 citations·filing 2018–2021
Top patents by PatentIndex Score
3 records- 0157US10799446B2Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and applicationREDWOOD PHARMA AB·Filed 2018·Granted Oct 13, 2020·0 cites·10 claims
- 0254US2020390695A1Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and applicationREDWOOD PHARMA AB·Filed 2020·Application pending·0 cites
- 0343US2023131227A1New use and method of treatmentREDWOOD PHARMA AB·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →